Susanna S Ng

10PUBLICATIONS
46CO-AUTHORS
Molecular targetsPredictive and prognostic markersInnate immunityImmunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 13, 2025
The Antibody-Drug Conjugate Sacituzumab Govitecan (IMMU-132) Represents a Potential Novel Therapeutic Strategy in Cholangiocarcinoma.

Racha Hosni, Niklas Klümper, Christine Sanders

|Mar 25, 2022
CD103+ Tissue Resident T-Lymphocytes Accumulate in Lung Metastases and Are Correlated with Poor Prognosis in ccRCC.

Christine Sanders, Almotasem Salah M Hamad, Susanna Ng

|Jan 11, 2022
NKG7 Is Required for Optimal Antitumor T-cell Immunity.

Xian-Yang Li, Dillon Corvino, Bianca Nowlan

|Oct 13, 2020
IL-27 signalling regulates glycolysis in Th1 cells to limit immunopathology during infection.

Marcela Montes de Oca, Fabian de Labastida Rivera, Clay Winterford

|Aug 26, 2020
The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation.

Susanna S Ng, Fabian De Labastida Rivera, Juming Yan

Pageof 2